Transurethral resection of the prostate

From Wikipedia, the free encyclopedia - View original article

Transurethral resection of the prostate
Intervention
Nodular hyperplasia of the prostate.jpg
Micrograph of a transurethral resection of the prostate (TURP) specimen, showing BPH (nodular hyperplasia of the prostate) - left-of-center in image. H&E stain.
ICD-9-CM60.29
MeSHD020728
MedlinePlus002996
 
Jump to: navigation, search
Transurethral resection of the prostate
Intervention
Nodular hyperplasia of the prostate.jpg
Micrograph of a transurethral resection of the prostate (TURP) specimen, showing BPH (nodular hyperplasia of the prostate) - left-of-center in image. H&E stain.
ICD-9-CM60.29
MeSHD020728
MedlinePlus002996

Transurethral resection of the prostate (commonly known as a TURP, plural TURPs, and rarely as a transurethral prostatic resection, TUPR) is a urological operation. It is used to treat benign prostatic hyperplasia (BPH). As the name indicates, it is performed by visualising the prostate through the urethra and removing tissue by electrocautery or sharp dissection. This is considered the most effective treatment for BPH. This procedure is done with spinal or general anaesthetic. A triple lumen catheter is inserted through the urethra to irrigate and drain the bladder after the surgical procedure is complete. Outcome is considered excellent for 80-90% of BPH patients.

Indications[edit]

BPH is normally initially treated medically. This is done through alpha antagonists such as Flomax or 5-alpha-reductase inhibitors such as Proscar and Avodart. If medical treatment does not reduce a patient's urinary symptoms, a TURP may be considered following a careful examination of the prostate/bladder through a cystoscope. If TURP is contraindicated a Urologist may consider: a simple prostatectomy, in and out catheters, or a supra-pubic catheter to help a patient void urine effectively.[1] As medical management of BPH improves, the numbers of TURPs have been decreasing.

Types of TURP[edit]

Risks[edit]

Because of bleeding risks associated with the surgery, TURP is not considered safe for many patients with cardiac problems.

Postoperative complications include [2]

Additionally, transurethral resection of the prostate is associated with a low risk of mortality.

See also[edit]

References[edit]

  1. ^ Collins, MD; Chief Editor: Edward David Kim, MD Transurethral Resection of the Prostate Medscape:
  2. ^ Rassweiler J, Teber D, Kuntz R, Hofmann R (November 2006). "Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention". Eur. Urol. 50 (5): 969–79; discussion 980. doi:10.1016/j.eururo.2005.12.042. PMID 16469429. 
  3. ^ Ö L Özdal, C Özden, K Benli, S Gökkaya, S Bulut and A Memis cedil Effect of short-term finasteride therapy on peroperative bleeding in patients who were candidates for transurethral resection of the prostate (TUR-P): a randomized controlled study Prostate Cancer and Prostatic Diseases (2005) 8, 215–218. doi:10.1038/sj.pcan.4500818; published online 5 July 2005 pubmed 15999118 http://www.nature.com/pcan/journal/v8/n3/full/4500818a.html
  4. ^ LI Ming-xiong,TANG Zheng-yan,SU Jian,et al. Effect of Finasteride on Perioperative and Postoperative Bleeding Following Transurethral Resection of Prostate http://en.cnki.com.cn/Article_en/CJFDTOTAL-SYYY200903092.htm DOI CNKI:SUN:SYYY.0.2009-03-092
  5. ^ Complications of Transurethral Resection of the Prostate (TURP)—Incidence, Management, and Prevention
  6. ^ Imiak et al. (1 Jan 1999). "TURP Syndrome". 

External links[edit]